UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$544.33
+6.03 (+1.12%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+7.33%
1Y
+87.74%
YTD
+9.58%
Open$542.08
Previous Close$538.30
Day High$546.58
Day Low$539.70
52W High$609.35
52W Low$272.12
Volume—
Avg Volume623.5K
Market Cap22.78B
P/E Ratio17.69
EPS$27.09
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$485.49
Above
SMA 200
$394.55
Above
RSI (14)
60.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-83.7% upside
Current
$544.33
$544.33
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.82B | 2.39B | 2.73B |
| Net Income | 1.18B | 901.94M | 406.29M |
| Profit Margin | 41.9% | 39.8% | 14.9% |
| EBITDA | 1.40B | 1.13B | 733.08M |
| Free Cash Flow | — | — | 513.48M |
| Rev Growth | +18.0% | +18.0% | +4.0% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |